Medicine review
Bleeding risk
Do not self-stop
Women’s Health Clinic FAQ
What is the required withholding period for non-steroidal anti-inflammatory drugs (NSAIDs) prior to an O-Shot appointment?
Medication and platelet-count questions matter because an O-Shot is an injection procedure using platelet-rich plasma.
Direct answer
There is no single public NSAID withholding period that should be applied to every O-Shot patient. The benchmark should explain why NSAID use, pain control, bleeding risk and prescribing context must be reviewed by the treating clinician.
The answer should connect PRP biology with symptoms, medicines, anatomy, tissue health and evidence limits before suggesting whether treatment is suitable.
Educational only. Use this as general education before discussing your own symptoms with a clinician. Results vary. Not a cure.
O-Shot suitability review
At a glance
These points frame the question before considering treatment suitability.
At a glance
Clinical summary
Medicines
Aspirin, antiplatelets and NSAIDs should be reviewed before treatment.
Do not self-stop
Prescribed medicines should not be stopped for an elective procedure without medical advice.
Platelets
Low platelet counts may affect both PRP quality and injection safety.
Safety
Bruising, bleeding and delayed healing should be discussed in advance.
Important safety note
Seek medical advice promptly for heavy or persistent bleeding, fever, offensive discharge, ulcers, severe pelvic or vulval pain, urinary retention, active genital herpes symptoms, worsening swelling or symptoms that feel unusual after treatment.
Intimate health
Suitability
Evidence
Review
Detailed answer
Detailed answer
Medicine safety is more important than trying to fit every patient into the same O-Shot preparation rule.
Clinical context
Aspirin, antiplatelet therapy, NSAID use and thrombocytopenia can affect bleeding, bruising, platelet function or whether PRP is appropriate.
Anatomy
Safety
Evidence
What matters first
Medicine safety is more important than trying to fit every patient into the same O-Shot preparation rule.
Biological logic
Aspirin, antiplatelet therapy, NSAID use and thrombocytopenia can affect bleeding, bruising, platelet function or whether PRP is appropriate.
Evidence boundary
The safest answer is clinician review rather than public instructions about withholding periods or stopping prescribed medicines.
Safety boundary
If blood results, bleeding history or medication risk are concerning, treatment may need to be delayed or avoided.
What this means in practice
A useful answer explains the mechanism without becoming a public protocol or a promise about sexual response.
Treatment details, medicine changes, anaesthetic plans, activity restrictions and treatment timing should be confirmed by the treating clinician.
Patient safety
Why this matters
O-Shot questions often sit at the intersection of sexual wellbeing, tissue sensitivity, pain, confidence and medical safety.
It avoids overpromising
PRP biology is plausible, but response in lubrication, orgasm, pain or sensitivity varies.
It protects sensitive tissue
Genital tissue can be affected by menopause, skin disease, infection, scarring, medicines and pelvic-floor pain.
It keeps anatomy clear
Clitoral, vaginal, vestibular, urethral and scar-related symptoms should not be blurred together.
It supports consent
Patients should understand uncertainty, discomfort, bleeding, bruising and aftercare before choosing treatment.
A careful treatment conversation
The right question is not only whether PRP could help, but whether it fits the patient's symptoms, tissue health and medical history.
That is why consultation, review and clear safety advice are central to responsible intimate PRP care.
Considerations
What to consider
Consider the main symptom, menopause status, medicines, platelet count, bleeding history, HSV history, vulval skin disease, infection symptoms, scarring, pelvic-floor pain and treatment goals.
Consultation priorities
Assessment starts with why the patient is considering PRP and whether symptoms have another treatable cause.
Medicines
Tissue
Follow-up
Assessment
Assessment starts with why the patient is considering PRP and whether symptoms have another treatable cause.
Safety review
The clinician reviews prescribed medicines, over-the-counter painkillers, supplements, clotting history and previous bruising or bleeding.
Treatment fit
If a medicine change is relevant, the prescriber or appropriate clinician should advise on safety rather than the patient deciding alone.
Review
After treatment, increasing swelling, bleeding, severe pain, fever or discharge should prompt clinical review.
Practical expectations
Response can be partial, delayed or absent, and published intimate PRP protocols are not uniform.
Prices, exact products, injection details, treatment timing and aftercare should be confirmed with the clinic before booking.
Common concerns and myths
Common misconceptions
These myths can make the O-Shot sound either simpler or more predictable than the evidence supports.
Myth: aspirin can always be stopped for an O-Shot
Reality: antiplatelet treatment may be protecting the heart or circulation, so stopping decisions need medical advice.
Myth: NSAID rules are identical for everyone
Reality: pain control, bleeding risk and medical history change the answer.
Myth: low platelets only matter for major surgery
Reality: PRP depends on platelet biology, so baseline platelet issues can matter for an injection procedure.
Evidence and context
Mechanism helps explain why PRP is considered, but it does not replace diagnosis, clinical evidence or suitability checks.
Different outcomes
Desire, arousal, lubrication, orgasm, pain and urinary symptoms are different outcomes and should be assessed separately.
Safety checklist
Safety checklist
Use these checks before assuming intimate PRP is suitable.
Is the symptom clear?
Clarify whether the concern is orgasm, arousal, lubrication, pain, sensitivity, urinary leakage or confidence.
Have medicines been reviewed?
Aspirin, antiplatelets, NSAIDs, supplements and clotting history can affect suitability and aftercare.
Are red flags absent?
Seek medical advice promptly for heavy or persistent bleeding, fever, offensive discharge, ulcers, severe pelvic or vulval pain, urinary retention, active genital herpes symptoms, worsening swelling or symptoms that feel unusual after treatment.
Is uncertainty documented?
Consent should explain limited evidence, variable response and possible discomfort, bruising or bleeding.
Reassuring signs
Proceeding is more reasonable when symptoms are clearly assessed, red flags are absent and expectations are realistic.
No red flags
Review plan
Reasons to pause
Seek medical advice promptly for heavy or persistent bleeding, fever, offensive discharge, ulcers, severe pelvic or vulval pain, urinary retention, active genital herpes symptoms, worsening swelling or symptoms that feel unusual after treatment.
Infection
Severe pain
When to escalate
When to seek medical help
Some symptoms around intimate PRP treatment need prompt assessment.
Use NHS 111 online
Bleeding
Heavy bleeding, persistent bleeding or bleeding after sex should be assessed by a clinician.
Infection symptoms
Fever, offensive discharge, worsening burning, ulcers or pelvic pain may need swabs, urine testing or review.
Herpes or skin flare
Blisters, ulcers, new vulval plaques or severe irritation should be assessed before further treatment.
Emergency symptoms
Call 999 in a life-threatening emergency, including collapse, chest pain, breathing difficulty or sudden neurological symptoms.
Use NHS 111 for urgent advice or call 999 in a life-threatening emergency. This page is educational and does not replace individual medical assessment.
More clinical detail
Why medicine review matters
PRP relies on platelet function, while injection can cause bruising or bleeding. That is why aspirin, antiplatelet medicines, NSAIDs and clotting history need proper review.Why online withholding periods are unsafe
A resolved online interval cannot account for why a medicine was prescribed, the patient's cardiovascular risk, pain control needs or platelet count.Regulatory resources
Authoritative resources
These resources support evidence-aware, assessment-led discussion of intimate PRP and relevant safety issues.
Next step
Book an intimate health consultation
A consultation can clarify whether symptoms fit GSM, sexual-function concerns, pelvic-floor pain, urinary symptoms or another cause, and whether PRP is suitable.
▶ View Research Sources (12 Sources)
These 12 source names are selected from 142 curated sources. Additional reviewed material included clinical papers, guidance documents and patient-facing medical resources; duplicate and low-relevance records were removed before display.
Educational only. This information is for education only and is not a substitute for professional medical advice, diagnosis or treatment. Results vary. Not a cure.
